Blog
RSS FeedPosted by Michael Wonder on 12 May 2023
Public Consultation: draft 2023-24 Cost Recovery Implementation Statement (CRIS) for listing medicines on the PBS and designated vaccines on the NIP
12 May 2023 - Consultation on the draft 2023-24 Cost Recovery Implementation Statement (CRIS) for listing medicines on the Pharmaceutical ...
Posted by Michael Wonder on 12 May 2023
Outcome in relation to fluticasone propionate – May 2023 PBAC intracycle meeting
12 May 2023 - The outcome for fluticasone propionate from the May 2023 PBAC meeting is now available. ...
Posted by Michael Wonder on 11 May 2023
May 2023 updates from the Health Technology Assessment Policy and Methods Review Reference Committee
11 May 2023 - Information regarding the experts in HTA to support the HTA Review is now available. ...
Posted by Michael Wonder on 10 May 2023
Recommendations made out-of-session by the PBAC between March 2023 and July 2023 meetings
10 May 2023 - Recommendations made out-of-session by the PBAC between its March 2023 and July 2023 meetings are now available. ...
Posted by Michael Wonder on 28 Apr 2023
Agenda for the May 2023 intracycle meeting
28 April 2023 - The agenda for the May 2023 PBAC intracycle meeting is now available. ...
Posted by Michael Wonder on 21 Apr 2023
Recommendations made by the PBAC (March 2023)
21 April 2023 - Recommendations made by the PBAC in March 2023 relating to the listing of medicines on the Pharmaceutical ...
Posted by Michael Wonder on 20 Apr 2023
Updates from the Health Technology Assessment Policy and Methods Review Reference Committee – March and April 2023
20 April 2023 - The Health Technology Assessment Policy and Methods Review Reference Committee met on 24 March 2023 and ...
Posted by Michael Wonder on 12 Apr 2023
HTA reform starts today – consultations open
11 April 2023 - Medicines Australia welcomes the official start of the Health Technology Assessment (HTA) Review consultation that should ...
Posted by Michael Wonder on 11 Apr 2023
Health technology assessment policy and methods review consultation
11 April 2023 - The first round of public consultation for the HTA Review is open. Submissions will be accepted ...
Posted by Michael Wonder on 06 Apr 2023
Public summary documents – December 2022 PBAC meeting
6 April 2023 - The public summary documents (positive recommendations and subsequent decisions not to recommend) from the December 2022 PBAC ...
Posted by Michael Wonder on 29 Mar 2023
Agenda for the July 2023 PBAC meeting
29 March 2023 - The agenda for the July 2023 PBAC meeting is now available. ...
Posted by Michael Wonder on 22 Mar 2023
HTA reform gets underway – terms of reference released today
22 March 2023 - Medicines Australia acknowledges the Health Technology Assessment Review Terms of Reference – released today – and ...
Posted by Michael Wonder on 22 Mar 2023
Terms of reference for the Health Technology Assessment Policy and Methods Review
22 March 2023 - The terms of reference for the Health Technology Assessment Policy and Methods Review is now available. ...
Posted by Michael Wonder on 19 Mar 2023
Public Summary Documents (first time decisions not to recommend and deferrals) - November 2022 PBAC meeting
17 March 2023 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the November 2022 PBAC ...
Posted by Michael Wonder on 14 Mar 2023
CEO’s appointment to HTA Review Reference Committee
15 March 2023 - CEO of Medicines Australia, Elizabeth de Somer, has been appointed as the medicines industry representative on ...